[Research advances in application of isobaric tags for relative and absolute quantitation in proteomics of hepatocellular carcinoma]
- PMID: 28073423
- DOI: 10.3760/cma.j.issn.1007-3418.2016.12.018
[Research advances in application of isobaric tags for relative and absolute quantitation in proteomics of hepatocellular carcinoma]
Abstract
Due to the features of strong heterogeneity, difficult early diagnosis, poor prognosis, and high fatality rate, hepatocellular carcinoma (HCC) has become an important disease which threatens the health of the Chinese population. Accurate early diagnosis is crucial to improving the success rate of liver cancer resection and reducing postoperative recurrence and metastasis, and its core is the screening and validation of biomarkers for early diagnosis. Isobaric tags for relative and absolute quantitation (iTRAQ) and stable isotope labeling with amino acids in cell culture are important parts of proteomics technology, and iTRAQ has become the most important technique in quantitative proteomics technology due to its advantages of high throughput, high quantitative accuracy, and no limitation by sample source. This article reviews the research advances in molecular mechanism of the development and progression of HCC and screening of markers, in order to establish a theoretical foundation for in-depth understanding of the molecular mechanisms of the development and progression of HCC and the development of new biomarkers.
Similar articles
-
Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics.J Proteome Res. 2016 Feb 5;15(2):487-98. doi: 10.1021/acs.jproteome.5b00838. Epub 2016 Jan 14. J Proteome Res. 2016. PMID: 26709725
-
Integrated Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) Quantitative Proteomic Analysis Identifies Galectin-1 as a Potential Biomarker for Predicting Sorafenib Resistance in Liver Cancer.Mol Cell Proteomics. 2015 Jun;14(6):1527-45. doi: 10.1074/mcp.M114.046417. Epub 2015 Apr 7. Mol Cell Proteomics. 2015. PMID: 25850433 Free PMC article. Clinical Trial.
-
Quantitative proteomics reveals FLNC as a potential progression marker for the development of hepatocellular carcinoma.Oncotarget. 2016 Oct 18;7(42):68242-68252. doi: 10.18632/oncotarget.11921. Oncotarget. 2016. PMID: 27626164 Free PMC article.
-
Quantitative proteomics for cancer biomarker discovery.Comb Chem High Throughput Screen. 2012 Mar;15(3):221-31. doi: 10.2174/138620712799218635. Comb Chem High Throughput Screen. 2012. PMID: 22221055 Review.
-
Current advances in tumor proteomics and candidate biomarkers for hepatic cancer.Expert Rev Proteomics. 2009 Oct;6(5):551-61. doi: 10.1586/epr.09.72. Expert Rev Proteomics. 2009. PMID: 19811076 Review.
Cited by
-
Clinical identification of expressed proteins in adrenal medullary hyperplasia detected with hypertension.Front Endocrinol (Lausanne). 2022 Dec 13;13:1014366. doi: 10.3389/fendo.2022.1014366. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36583008 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical